InsiderTrades

Form 4 for SNDX Syndax Pharmaceuticals Inc

Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-15 · accession 0001562180-22-006705 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-09-16 2022-09-15+ SNDX Podlesak Dennis Dir S - Sale+OE $24.08 -78.8K 75.8K -51% -$1.90M
DM 2022-09-16 2022-09-15+ SNDX Podlesak Dennis Dir M - OptEx $6.32 +78.8K 81.2K +3,330% +$498.3K
DM 2022-09-16 2022-09-15+ SNDX Podlesak Dennis Dir M - OptEx $0.00 -78.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-09-16 S D 5,419 $23.43 75,763 D — — (F3) The sale prices ranged from $22.96 to $24.07
2 Common Common Stock 2022-09-16 M A 6,556 $6.35 82,319 D — —
3 Common Common Stock 2022-09-16 S D 6,556 $23.43 75,763 D — — (F3) The sale prices ranged from $22.96 to $24.07
4 Common Common Stock 2022-09-15 M A 66,840 $6.32 142,603 D — —
5 Common Common Stock 2022-09-15 S D 66,840 $24.20 75,763 D — — (F2) The sale prices ranged from $23.37 to $24.64
6 Common Common Stock 2022-09-16 M A 5,419 $6.32 81,182 D — —
7 Derivative Stock Options (Right to buy) 2022-09-16 M D 6,556 $0.00 0 D $6.35 · — to 2024-12-18 6,556 Common Stock (F4) This option is fully vested.
8 Derivative Stock Options (Right to buy) 2022-09-16 M D 5,419 $0.00 0 D $6.32 · — to 2024-09-15 5,419 Common Stock (F4) This option is fully vested.
9 Derivative Stock Options (Right to buy) 2022-09-15 M D 66,840 $0.00 0 D $6.32 · — to 2024-09-15 66,840 Common Stock (F4) This option is fully vested.